Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hana Hortová"'
Autor:
Irena Rektorová, Evžen Růžička, Martin Bareš, Jan Roth, Petr Kaňovský, Hana Hortová, B. Hejduková, Petr Mečíř, Robert Jech, Hana Streitová, Ivan Rektor
Publikováno v:
Journal of Neural Transmission. 107:1297-1306
Efficiency and safety of amantadine sulfate (AMS) infusions were investigated in late stage complications of Parkinson's disease (PD). In an open-label study, 21 PD patients suffering from motor fluctuations and/or dyskinesias were administered AMS i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9acccc43a12d70ffe240f46fceec71c0
https://doi.org/10.1007/s007020070019
https://doi.org/10.1007/s007020070019
Publikováno v:
Movement Disorders. 14:886-888
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b50433621a721aed75a202007dd1d9aa
https://doi.org/10.1002/1531-8257(199909)14:5<886::aid-mds1034>3.0.co
https://doi.org/10.1002/1531-8257(199909)14:5<886::aid-mds1034>3.0.co
Autor:
Evzen Ruzicka, Werner Poewe, P. Kanovsky, A. Richardson, Jan Roth, Martin Bareš, J. Müller, Jörg Wissel, P. Schnider, Hana Streitová, Eduard Auff, Hana Hortová, Christian Brenneis, Robert Jech
Publikováno v:
Journal of neurology. 248(12)
Results from a dose-ranging study in a selected group of de novo patients with rotational cervical dystonia (CD) suggest that 500 units of Dysport (Clostridium botulinum toxin type A haemaglutinin complex) is the optimal starting dose. The present st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3a55de7e560e7312e580a72a352fcc
https://pubmed.ncbi.nlm.nih.gov/12013585
https://pubmed.ncbi.nlm.nih.gov/12013585
Autor:
Petr Kaňovský, Martin Bareš, Vladimír Znojil, Dagmar Kubová, Hana Streitová, Ivan Rektor, Hana Hortová
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 17(1)
Twelve patients with levodopa-induced dyskinesias were treated with continuous subcutaneous apomorphine. A markedly significant reduction in peak dose dyskinesias occurred over a two-year follow-up.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48dd359877f1e228f4a70545b682cd02
https://pubmed.ncbi.nlm.nih.gov/11835461
https://pubmed.ncbi.nlm.nih.gov/11835461
Publikováno v:
Journal of the Neurological Sciences. 150:S181
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3324e3745734723bd95cdf7cc9cd31a3
https://doi.org/10.1016/s0022-510x(97)85749-8
https://doi.org/10.1016/s0022-510x(97)85749-8